Cases 141 - 150 of 394
Comanche County Memorial Hospital, v. Genentech Inc. et al
as 3:2016cv02498
Plaintiff:
Comanche County Memorial Hospital,
Defendant:
Genentech Inc. , Roche Holding AG, Roche Holding Ltd. and others
Cause Of Action: 28 U.S.C. § 1332
In re Baxalta Incorporated & Baxalta GmbH
as 3:2016mc80087
Plaintiff:
Baxalta Incorporated and Baxalta GmbH
Defendant:
Genentech, Inc.
Plaintiff v. Defendant
as 1:2016cv01330
Plaintiff:
Plaintiff v. Defendant
Defendant:
Plaintiff v. Defendant
Cause Of Action: 42 U.S.C. § 12101
Hematology-Oncology Associates of Central New York, P.C. v. Genentech Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00221
Plaintiff:
Hematology-Oncology Associates of Central New York, P.C.
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Minnesota Oncology Hematology, P.A. v. Genentech Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00210
Plaintiff:
Minnesota Oncology Hematology, P.A.
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Cancer Care Network of South Texas, P.A. v. Genentech Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00205
Plaintiff:
Cancer Care Network of South Texas, P.A.
Defendant:
Genentech Inc.
Cause Of Action: 28 U.S.C. § 1332
Tennessee Oncology, PLLC v. Genentech Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00203
Plaintiff:
Tennessee Oncology, PLLC
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Florida Cancer Specialists, P.L. v. Genentech, Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00204
Plaintiff:
Florida Cancer Specialists, P.L.
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
Virginia Oncology Associates, P.C. v. Genentech Inc.. ***ALL FILINGS in this member case must also be made in the MDL master case 16-md-2700.***
as 4:2016cv00206
Plaintiff:
Virginia Oncology Associates, P.C.
Defendant:
Genentech Inc.
Cause Of Action: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation
In Re: MDL 2700 Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation ***ALL FILINGS in this MDL master case must also be made in the affected individual member cases.***
as 4:2016md02700
Plaintiff:
Tulsa Cancer Institute, PLLC , Oklahoma Oncology & Hematology, Inc. , State of Oklahoma and others
Defendant:
Genentech, Inc.
Cause Of Action: No cause code entered
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
